2 Stocks That Could More Than Double Your Money, According to Wall Street: Are They Buys Now?
Investors looking for stocks that can produce dramatic gains over the next 12 months want to turn their attention to the biotechnology industry. Wall Street analysts tasked with following a synthetic biology company called Ginkgo Bioworks (NYSE: DNA) think it can more than double your money.
Investment bankers also have high hopes for Agenus (NASDAQ: AGEN). The latest price targets on the cancer drug developer suggest it can shoot more than 700% higher.
Shares of Ginkgo Bioworks are down about 54% from a peak they hit last summer. Investment bank analysts at TD Cowen think it can rebound. In March, the bank lowered its price target on the stock to $3 per share. The lowered target still implies a gain of over 150% from the stock's recent price.
Source Fool.com
Toronto-Dominion Bank Aktie
Ausgeglichenes Verhältnis bei der Toronto-Dominion Bank Aktie mit 3 Buy- und 2 Sell-Einschätzungen.
Dadurch ergibt sich bei einem Kursziel von 86 € ein stark positives Potenzial von 64.97% im Vergleich zum aktuellen Kurs von 52.13 € bei Toronto-Dominion Bank.
